Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different doses of methylprednisolone in cardiopulmonary bypass patients
IRCT201010233438N2Phase 3Completed
- Sponsor
- Iranian Blood Transfusion Organization
- Start
- Oct 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylprednisolone in coronary arteriosclerosis (2 arms), sponsored by Iranian Blood Transfusion Organization. Primary endpoints: Platelet function and Fibrinolysis system. Started Oct 2010; status: completed.
02
Drugs
methylprednisolone
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT201010233438N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201010233438N2.